Drug Shortage Report for VYZULTA
Report ID | 153548 |
Drug Identification Number | 02484218 |
Brand name | VYZULTA |
Common or Proper name | VYZULTA |
Company Name | BAUSCH & LOMB INC |
Market Status | MARKETED |
Active Ingredient(s) | LATANOPROSTENE BUNOD |
Strength(s) | 0.024% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 5ml |
ATC code | S01EE |
ATC description | |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2022-01-17 |
Estimated end date | 2022-01-31 |
Actual end date | 2022-02-09 |
Shortage status | Resolved |
Updated date | 2022-02-10 |
Company comments | production delay |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1400 N GOODMAN STREET ROCHESTER, NEW YORK UNITED STATES 14609 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-01-26 | English | Compare |
v2 | 2022-01-26 | French | Compare |
v3 | 2022-02-09 | English | Compare |
v4 | 2022-02-09 | French | Compare |
v5 | 2022-02-10 | English | Compare |
Showing 1 to 5 of 5